Verdicts genuinely change. Free email alert the moment HIAHX's does — no target price to set, unlike "Alert" above.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
HARTFORD HEALTHCARE HLS FUND · HARTFORD SERIES FUND INC
79 holdings
NON-COMPLIANT 22.07% of portfolio weight is in non-compliant holdings, over the 5% threshold.
79 holdings, 62 matched (94% of weight). Portfolio as of 2026-06-30, filed 2026-08-28. Source: SEC Form N-PORT.
2.72% of this portfolio’s income is non-permissible — weighted across holdings, computed over 84% of portfolio weight (50 of 79 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
69.6% compliant 0.0% questionable 22.1% non-compliant 6.1% unscreened
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| LLY Eli Lilly & Co | COMPLIANT | 12.47% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| JNJ Johnson & Johnson | COMPLIANT | 6.63% | AAOIFI7.6% Usmani24.4% Dow Jones Islamic10.9% S&P Shariah11.7% MSCI Islamic24.4% MSCI Islamic M-Series11.7% FTSE Shariah24.4% |
| MRK Merck & Co Inc | COMPLIANT | 6.60% | AAOIFI14.7% Usmani41.5% Dow Jones Islamic21.8% S&P Shariah20.9% MSCI Islamic41.5% MSCI Islamic M-Series20.9% FTSE Shariah41.5% |
| UNH UnitedHealth Group Inc | NON_COMPLIANT | 4.72% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| ABBV AbbVie Inc | COMPLIANT | 3.43% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| ISRG Intuitive Surgical Inc | COMPLIANT | 2.99% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| ELV Elevance Health Inc | NON_COMPLIANT | 2.96% | AAOIFI35.1% Usmani24.6% Dow Jones Islamic37.4% S&P Shariah33.5% MSCI Islamic24.6% MSCI Islamic M-Series33.5% FTSE Shariah24.6% |
| CVS CVS Health Corp | NON_COMPLIANT | 2.93% | AAOIFI61.7% Usmani30.1% Dow Jones Islamic84.9% S&P Shariah88.7% MSCI Islamic30.1% MSCI Islamic M-Series88.7% FTSE Shariah24.2% |
| VRTX Vertex Pharmaceuticals Inc | COMPLIANT | 2.69% | AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| DHR Danaher Corp | COMPLIANT | 2.65% | AAOIFI18.2% Usmani28.8% Dow Jones Islamic17.7% S&P Shariah16.7% MSCI Islamic28.8% MSCI Islamic M-Series16.7% FTSE Shariah28.8% |
| EW Edwards Lifesciences Corp | COMPLIANT | 2.42% | AAOIFI1.4% Usmani5.1% Dow Jones Islamic1.5% S&P Shariah1.5% MSCI Islamic5.1% MSCI Islamic M-Series1.5% FTSE Shariah4.3% |
| ABT Abbott Laboratories | COMPLIANT | 2.10% | AAOIFI19.2% Usmani31.9% Dow Jones Islamic17.6% S&P Shariah18.3% MSCI Islamic31.9% MSCI Islamic M-Series18.3% FTSE Shariah30.8% |
| COR Cencora Inc | COMPLIANT | 2.07% | AAOIFI18.9% Usmani14.0% Dow Jones Islamic20.8% S&P Shariah22.7% MSCI Islamic14.0% MSCI Islamic M-Series22.7% FTSE Shariah14.0% |
| CAH Cardinal Health Inc | COMPLIANT | 1.81% | AAOIFI17.8% Usmani17.7% Dow Jones Islamic24.8% S&P Shariah28.7% MSCI Islamic17.4% MSCI Islamic M-Series28.7% FTSE Shariah15.5% |
| TMO Thermo Fisher Scientific Inc | COMPLIANT | 1.64% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| HCA HCA Healthcare Inc | NON_COMPLIANT | 1.60% | AAOIFI57.2% Usmani82.9% Dow Jones Islamic53.5% S&P Shariah56.7% MSCI Islamic81.7% MSCI Islamic M-Series56.7% FTSE Shariah78.1% |
| REGN Regeneron Pharmaceuticals Inc | COMPLIANT | 1.52% | AAOIFI2.4% Usmani6.5% Dow Jones Islamic3.0% S&P Shariah2.7% MSCI Islamic4.8% MSCI Islamic M-Series2.7% FTSE Shariah4.8% |
| BIIB Biogen Inc | COMPLIANT | 1.41% | AAOIFI21.2% Usmani22.5% Dow Jones Islamic27.5% S&P Shariah24.3% MSCI Islamic22.5% MSCI Islamic M-Series24.3% FTSE Shariah21.3% |
| A Agilent Technologies Inc | COMPLIANT | 1.36% | AAOIFI9.3% Usmani28.3% Dow Jones Islamic10.8% S&P Shariah10.7% MSCI Islamic28.3% MSCI Islamic M-Series10.7% FTSE Shariah28.3% |
| GSK GSK PLC | COMPLIANT | 1.21% | AAOIFI19.2% Usmani23.6% Dow Jones Islamic10.6% S&P Shariah11.2% MSCI Islamic23.6% MSCI Islamic M-Series11.2% FTSE Shariah23.6% |
| BSX Boston Scientific Corp | COMPLIANT | 1.19% | AAOIFI19.4% Usmani27.9% Dow Jones Islamic10.0% S&P Shariah10.9% MSCI Islamic27.9% MSCI Islamic M-Series10.9% FTSE Shariah27.9% |
| SYK Stryker Corp | COMPLIANT | 1.17% | AAOIFI14.6% Usmani32.2% Dow Jones Islamic11.3% S&P Shariah11.8% MSCI Islamic32.2% MSCI Islamic M-Series11.8% FTSE Shariah31.2% |
| CNC Centene Corp | NON_COMPLIANT | 1.16% | AAOIFI50.5% Usmani19.4% Dow Jones Islamic62.6% S&P Shariah53.4% MSCI Islamic19.4% MSCI Islamic M-Series53.4% FTSE Shariah19.4% |
| MDT Medtronic PLC | COMPLIANT | 1.02% | AAOIFI24.4% Usmani31.5% Dow Jones Islamic26.4% S&P Shariah27.4% MSCI Islamic31.4% MSCI Islamic M-Series27.4% FTSE Shariah30.2% |
| UTHR United Therapeutics Corp | NON_COMPLIANT | 0.96% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| INCY Incyte Corp | COMPLIANT | 0.94% | AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.3% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| DXCM Dexcom Inc | COMPLIANT | 0.91% | AAOIFI4.1% Usmani21.7% Dow Jones Islamic4.7% S&P Shariah4.0% MSCI Islamic20.9% MSCI Islamic M-Series4.0% FTSE Shariah19.3% |
| ARGX Argenx SE | COMPLIANT | 0.83% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| UCB.BR UCB SA | COMPLIANT | 0.80% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| IONS Ionis Pharmaceuticals Inc | NON_COMPLIANT | 0.79% | AAOIFI21.0% Usmani67.5% Dow Jones Islamic23.0% S&P Shariah25.1% MSCI Islamic67.5% MSCI Islamic M-Series25.1% FTSE Shariah58.8% |
| STE STERIS PLC | COMPLIANT | 0.76% | AAOIFI9.4% Usmani19.1% Dow Jones Islamic9.1% S&P Shariah9.3% MSCI Islamic19.1% MSCI Islamic M-Series9.3% FTSE Shariah17.6% |
| ASND Ascendis Pharma A/S | COMPLIANT | 0.76% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| MDGL Madrigal Pharmaceuticals Inc | COMPLIANT | 0.74% | AAOIFI2.8% Usmani27.9% Dow Jones Islamic3.8% S&P Shariah4.6% MSCI Islamic27.9% MSCI Islamic M-Series4.6% FTSE Shariah27.4% |
| CYTK Cytokinetics Inc | NON_COMPLIANT | 0.73% | AAOIFI3.9% Usmani20.7% Dow Jones Islamic5.9% S&P Shariah6.2% MSCI Islamic20.7% MSCI Islamic M-Series6.2% FTSE Shariah14.3% |
| PTCT PTC Therapeutics Inc | NON_COMPLIANT | 0.71% | AAOIFI11.9% Usmani21.4% Dow Jones Islamic16.9% S&P Shariah20.0% MSCI Islamic21.2% MSCI Islamic M-Series20.0% FTSE Shariah18.2% |
| ALNY Alnylam Pharmaceuticals Inc | COMPLIANT | 0.70% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| Revolution Medicines Inc | UNSCREENED | 0.70% | no in-house ratios for this holding |
| ELAN Elanco Animal Health Inc | NON_COMPLIANT | 0.68% | AAOIFI31.2% Usmani27.5% Dow Jones Islamic41.7% S&P Shariah45.2% MSCI Islamic27.5% MSCI Islamic M-Series45.2% FTSE Shariah27.5% |
| BMY Bristol-Myers Squibb Co | NON_COMPLIANT | 0.66% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| Fixed Income Clearing Corp. | UNSCREENED | 0.65% | no in-house ratios for this holding |
| PTGX Protagonist Therapeutics Inc | NON_COMPLIANT | 0.63% | AAOIFI0.1% Usmani1.0% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic1.0% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| RCUS Arcus Biosciences Inc | COMPLIANT | 0.62% | AAOIFI3.0% Usmani12.3% Dow Jones Islamic5.9% S&P Shariah6.5% MSCI Islamic12.3% MSCI Islamic M-Series6.5% FTSE Shariah10.9% |
| AZN AstraZeneca PLC | COMPLIANT | 0.61% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| GALDY Galderma Group AG | COMPLIANT | 0.59% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| Dianthus Therapeutics Inc | UNSCREENED | 0.57% | no in-house ratios for this holding |
| KYMR Kymera Therapeutics Inc | NON_COMPLIANT | 0.56% | AAOIFI0.8% Usmani4.8% Dow Jones Islamic1.7% S&P Shariah2.1% MSCI Islamic4.6% MSCI Islamic M-Series2.1% FTSE Shariah0.0% |
| AMGN Amgen Inc | COMPLIANT | 0.55% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| BBIO Bridgebio Pharma Inc | COMPLIANT | 0.55% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| Pharvaris NV | UNSCREENED | 0.54% | no in-house ratios for this holding |
| EHC Encompass Health Corp | COMPLIANT | 0.53% | AAOIFI23.9% Usmani38.1% Dow Jones Islamic26.5% S&P Shariah29.4% MSCI Islamic38.1% MSCI Islamic M-Series29.4% FTSE Shariah35.3% |
| Disc Medicine Inc | UNSCREENED | 0.51% | no in-house ratios for this holding |
| ICLR ICON PLC | COMPLIANT | 0.51% | AAOIFI17.7% Usmani13.7% Dow Jones Islamic16.8% S&P Shariah13.2% MSCI Islamic13.7% MSCI Islamic M-Series13.2% FTSE Shariah12.9% |
| ADPT Adaptive Biotechnologies Corp | COMPLIANT | 0.49% | AAOIFI2.0% Usmani11.8% Dow Jones Islamic3.9% S&P Shariah5.1% MSCI Islamic11.8% MSCI Islamic M-Series5.1% FTSE Shariah0.0% |
| GPCR Structure Therapeutics Inc | NON_COMPLIANT | 0.48% | AAOIFI0.2% Usmani0.4% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.4% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| Scholar Rock Holding Corp | UNSCREENED | 0.48% | no in-house ratios for this holding |
| HTFL HeartFlow Inc | COMPLIANT | 0.47% | AAOIFI0.6% Usmani7.9% Dow Jones Islamicpass S&P Shariahpass MSCI Islamic7.9% MSCI Islamic M-Seriespass FTSE Shariah0.0% |
| MIRM Mirum Pharmaceuticals Inc | COMPLIANT | 0.46% | AAOIFI11.6% Usmani73.0% Dow Jones Islamic20.3% S&P Shariah25.7% MSCI Islamic73.0% MSCI Islamic M-Series25.7% FTSE Shariah71.8% |
| ALHC Alignment Healthcare Inc | COMPLIANT | 0.45% | AAOIFI11.6% Usmani25.3% Dow Jones Islamic10.0% S&P Shariah12.5% MSCI Islamic25.3% MSCI Islamic M-Series12.5% FTSE Shariah25.3% |
| IMCR Immunocore Holdings PLC | NON_COMPLIANT | 0.44% | AAOIFI24.8% Usmani42.8% Dow Jones Islamic29.4% S&P Shariah24.5% MSCI Islamic42.8% MSCI Islamic M-Series24.5% FTSE Shariah39.2% |
| OPCH Option Care Health Inc | NON_COMPLIANT | 0.43% | AAOIFI35.7% Usmani37.6% Dow Jones Islamic27.4% S&P Shariah25.9% MSCI Islamic37.6% MSCI Islamic M-Series25.9% FTSE Shariah34.3% |
| Vaxcyte Inc | UNSCREENED | 0.43% | no in-house ratios for this holding |
| Celldex Therapeutics Inc | UNSCREENED | 0.43% | no in-house ratios for this holding |
| QGEN QIAGEN NV | COMPLIANT | 0.41% | AAOIFI20.8% Usmani28.9% Dow Jones Islamic18.9% S&P Shariah18.9% MSCI Islamic28.9% MSCI Islamic M-Series18.9% FTSE Shariah26.3% |
| State Street Global Advisors | UNSCREENED | 0.38% | no in-house ratios for this holding |
| KLRA Kailera Therapeutics Inc | NON_COMPLIANT | 0.38% | AAOIFI0.5% Usmani0.8% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.8% MSCI Islamic M-Series— FTSE Shariah0.0% |
| CG oncology Inc | UNSCREENED | 0.38% | no in-house ratios for this holding |
| Trevi Therapeutics Inc | UNSCREENED | 0.36% | no in-house ratios for this holding |
| ACHC Acadia Healthcare Co Inc | NON_COMPLIANT | 0.34% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| STOK Stoke Therapeutics Inc | NON_COMPLIANT | 0.32% | AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic0.7% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| IMNM Immunome Inc | NON_COMPLIANT | 0.31% | AAOIFI0.2% Usmani0.8% Dow Jones Islamic0.3% S&P Shariah0.4% MSCI Islamic0.8% MSCI Islamic M-Series0.4% FTSE Shariah0.0% |
| 600276.SS Jiangsu Hengrui Pharmaceuticals Co Ltd | COMPLIANT | 0.30% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| Definium Therapeutics Inc | UNSCREENED | 0.30% | no in-house ratios for this holding |
| INSP Inspire Medical Systems Inc | COMPLIANT | 0.30% | AAOIFI1.6% Usmani3.1% Dow Jones Islamic0.8% S&P Shariah0.7% MSCI Islamic3.1% MSCI Islamic M-Series0.7% FTSE Shariah0.0% |
| 2595.HK GenFleet Therapeutics Shanghai Inc | NON_COMPLIANT | 0.28% | AAOIFI0.9% Usmani5.4% Dow Jones Islamicfail S&P Shariahfail MSCI Islamic4.6% MSCI Islamic M-Seriesfail FTSE Shariah4.6% |
| Crinetics Pharmaceuticals Inc | UNSCREENED | 0.23% | no in-house ratios for this holding |
| Avalyn Pharma Inc | UNSCREENED | 0.07% | no in-house ratios for this holding |
| Alebund Pharmaceuticals Jiangsu Ltd | UNSCREENED | 0.06% | no in-house ratios for this holding |
| Alamar Biosciences Inc | UNSCREENED | 0.03% | no in-house ratios for this holding |
| CONTRA ABIOMED INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
The published standards disagree about this fund by 27 points of portfolio weight — 65.4% of it passes AAOIFI, 37.9% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 65.4% ratios fail on 17.9% 14.6% not rated under AAOIFI
ratios pass on 45.2% ratios fail on 38.1% 14.6% not rated under Usmani
ratios pass on 61.9% ratios fail on 20.5% 15.4% not rated under Dow Jones Islamic
ratios pass on 63.7% ratios fail on 18.2% 15.9% not rated under S&P Shariah
ratios pass on 37.9% ratios fail on 48.5% 11.4% not rated under MSCI Islamic
ratios pass on 61.9% ratios fail on 20.5% 15.4% not rated under MSCI Islamic M-Series
ratios pass on 44.0% ratios fail on 39.2% 14.6% not rated under FTSE Shariah
62 of 79 listed holdings carry our own per-methodology verdicts (92% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 50 (82% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| UNH UnitedHealth Group Inc | 4.72% |
| ELV Elevance Health Inc | 2.96% |
| CVS CVS Health Corp | 2.93% |
| HCA HCA Healthcare Inc | 1.60% |
| CNC Centene Corp | 1.16% |
| UTHR United Therapeutics Corp | 0.96% |
| IONS Ionis Pharmaceuticals Inc | 0.79% |
| CYTK Cytokinetics Inc | 0.73% |
| PTCT PTC Therapeutics Inc | 0.71% |
| ELAN Elanco Animal Health Inc | 0.68% |
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
HARTFORD HEALTHCARE HLS FUND (HIAHX) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A holding it cannot cover far enough is reported as unrated rather than counted as a pass.
| Holding | Weight | Verdict |
|---|---|---|
| LLYEli Lilly & Co | 12.47% | Compliant |
| JNJJohnson & Johnson | 6.63% | Compliant |
| MRKMerck & Co Inc | 6.60% | Compliant |
| UNHUnitedHealth Group Inc | 4.72% | Non-compliant |
| ABBVAbbVie Inc | 3.43% | Compliant |
| ISRGIntuitive Surgical Inc | 2.99% | Compliant |
| ELVElevance Health Inc | 2.96% | Non-compliant |
| CVSCVS Health Corp | 2.93% | Non-compliant |
| VRTXVertex Pharmaceuticals Inc | 2.69% | Compliant |
| DHRDanaher Corp | 2.65% | Compliant |
Top 10 of 79 holdings, 48.1% of the fund by weight. Every holding is screened, not only these.
The positions keeping this fund short of 100% compliant by weight.
Verdict history for HIAHX. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
ℹ️ no compliance scan has run for 3 days - this is not a reading of today
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
This fund prices once a day, so its bars carry no intraday high or low — floor-trader pivots are not defined for it.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 53.00 | NEUTRAL |
| Stochastic %K (14) | 92.31 | SELL |
| CCI (20) | 65.83 | NEUTRAL |
| Williams %R (14) | -7.69 | SELL |
| MACD (12,26,9) | 0.02 | BUY |
| ROC (10) | 1.21 | BUY |
| Momentum (10) | 0.22 | BUY |
| EMA (10) | 18.26 | BUY |
| SMA (10) | 18.17 | BUY |
| EMA (20) | 18.30 | BUY |
| SMA (20) | 18.29 | BUY |
| EMA (30) | 18.34 | BUY |
| SMA (30) | 18.37 | BUY |
| EMA (50) | 18.30 | BUY |
| SMA (50) | 18.53 | SELL |
| EMA (100) | 18.00 | BUY |
| SMA (100) | 18.00 | BUY |
| EMA (200) | 17.44 | BUY |
| SMA (200) | 17.31 | BUY |
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
The questions worth asking about any verdict on this page, answered plainly.
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.